Tobias Sydendal Grand

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Tobias Sydendal Grand is an author at Novo Nordisk (Denmark) specializing in pharmacy, cost-effectiveness analysis, and societal perspective analysis.

ORCID

Publications per year

2018–2021

Publications

The long-term cost-effectiveness of oral semaglutide in the Netherlands based on the PIONEER 2, 3 and 4 randomized controlled trials

Samuel J. P. Malkin, Barnaby Hunt, Eline L. Huisman et al. · Diabetes Research and Clinical Practice · 2021 · 18 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +17

Utility elicitation in adults and children for allergic rhinoconjunctivitis and associated health states

Jenny Retzler, Tobias Sydendal Grand, A. Domdey et al. · Quality of Life Research · 2018 · 15 citations · Full text

Pharmacy, Child Health, Pharmacoeconomics +17

The cost-effectiveness of oral contraceptives compared to ‘no hormonal treatment’ for endometriosis-related pain: An economic evaluation

Tobias Sydendal Grand, Hasan Basarir, Louise Jackson · PLoS ONE · 2019 · 12 citations · Full text

Pharmacy, Gynecology, Pharmacoeconomics +17

1–3 of 3